Albert Khouri, MD
Enriched profileProfessor of Ophthalmology, Director of the Glaucoma Division, and Program Director of the Ophthalmology Residency · Rutgers New Jersey Medical School
Albert Khouri is Professor of Ophthalmology, Director of the Glaucoma Division, and Program Director of the Ophthalmology Residency at Rutgers New Jersey Medical School. OpenAlex indexes 285 publications with 1,801 citations (h-index 21); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Albert S. Khouri, MD, is Professor of Ophthalmology, Director of the Glaucoma Division, and Program Director of the Ophthalmology Residency at Rutgers New Jersey Medical School, Department of Ophthalmology & Visual Science. The public record shows 285 publications with 1,801 citations (h-index 21), centered on Glaucoma. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 15 companies.
- Most recent indexed publication: 2024 · Journal of current glaucoma practice
- Top research focus: Glaucoma
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 15 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Updated 27 Aug 2026
15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year202552 payments$66,154openpaymentsdata.cms.gov ↗
- Alcon Vision LLCProgram year202517 payments$20,407openpaymentsdata.cms.gov ↗
- Glaukos CorporationProgram year20255 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
88.7%Prostaglandin Analog28.8%Latanoprost59%Lumigan31%Travoprost6%Bimatoprost1%Zioptan1%Tafluprost1%Travatan Z1%Part D<11 patientsCarbonic Anhydrase Inhibitor28.4%Dorzolamide-Timolol56%Dorzolamide Hcl19%Simbrinza14%Acetazolamide4%Brinzolamide4%Acetazolamide Er1%Azopt1%Part D<11 patientsCardiovascular
6.9%Beta blocker6.9%Timolol Maleate100%Part D≥112 patientsCancer & immunology
1.6%Calcineurin inhibitor1.6%Restasis77%Cyclosporine24%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- MicroPulse Transscleral Laser Therapy: A Retrospective Study of Dose Efficacy and Safety.
Journal of current glaucoma practice
Article2024 - The environmental and economic burden of surgical waste in ophthalmology operating rooms.
Eye (London, England)
Article2024 - Ab interno trabeculectomy with the dual blade in juvenile open-angle glaucoma.
European journal of ophthalmology
Case Report2021 - Tele-glaucoma versus clinical evaluation: The New Jersey Health Foundation Prospective Clinical Study.
Journal of telemedicine and telecare
Article2020 - Software-Assisted Depth Analysis of Optic Nerve Stereoscopic Images in Telemedicine.
International journal of telemedicine and applications
Article2016
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/albert-khouri-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/albert-khouri-a0a4a58b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - LinkedIn
LinkedIn: "Albert Khouri - Professor of Ophthalmology, Glaucoma Director, Residency Director at Rutgers New Jersey Medical School"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
- Board Certified
Ophthalmology (American Board of Ophthalmology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Editorial & leadership roles
journal and society appointments- Program Director
Ophthalmology Residency, Rutgers New Jersey Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗ - Director
Glaucoma Division, Rutgers New Jersey Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗ - Medical Director
Ophthalmology Telemedicine, Rutgers New Jersey Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →glaucomatoday.com ↗
Secondary affiliations
appointments beyond the home institution- University Hospital
Newark, NJ (hospital affiliation)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
Media & interviews
press, podcasts and appearances- Guest
"Telemedicine in Glaucoma" episode (S2E9), Eye Tea Ophthalmology Podcast, with Drs. Ben Szirth and Natasha Kolomeyer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eyetea.club ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David Alland, MD
Rutgers New Jersey Medical School
Jerrold Ellner, MD
Rutgers New Jersey Medical School
George Kihiczak, MD
Rutgers New Jersey Medical School
Donald Cinotti, MD
Rutgers New Jersey Medical School